SEARCH

SEARCH BY CITATION

References

  • Acosta, J., Hettinga, J., Fluckiger, R., Krumrei, N., Goldfine, A., Angarita, L. & Halperin, J. (2000) Molecular basis for a link between complement and the vascular complications of diabetes. Proceedings of the National Academy of Sciences of the United States of America, 97, 54505455.
  • Adams, R.J., Kutlar, A., McKie, V., Carl, E., Nichols, F.T., Liu, J.C., McKie, K. & Clary, A. (1994) Alpha thalassemia and stroke risk in sickle cell anemia. American Journal of Hematology, 45, 279282.
  • Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J. & Loukopoulos, D. (2001) Cardiac involvement in thalassemia intermedia: a multicenter study. Blood, 97, 34113416.
  • Aggeli, C., Antoniades, C., Cosma, C., Chrysohoou, C., Tousoulis, D., Ladis, V., Karageorga, M., Pitsavos, C. & Stefanadis, C. (2005) Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. International Journal of Cardiology, 105, 8084.
  • Aliyu, Z.Y., Gordeuk, V., Sachdev, V., Babadoko, A., Mamman, A.I., Akpanpe, P., Attah, E., Suleiman, Y., Aliyu, N., Yusuf, J., Mendelsohn, L., Kato, G.J. & Gladwin, M.T. (2008) Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. American Journal of Hematology, 83, 485490.
  • Allan, D., Limbrick, A.R., Thomas, P. & Westerman, M.P. (1982) Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature, 295, 612613.
  • Andrieu, V., Dumonceau, O. & Grange, M.J. (2003) Priapism in a patient with unstable hemoglobin: hemoglobin Koln. American Journal of Hematology, 74, 7374.
  • Aslan, M., Ryan, T.M., Adler, B., Townes, T.M., Parks, D.A., Thompson, J.A., Tousson, A., Gladwin, M.T., Patel, R.P., Tarpey, M.M., Batinic-Haberle, I., White, C.R. & Freeman, B.A. (2001) Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proceedings of the National Academy of Sciences of the United States of America, 98, 1521515220.
  • Asleh, R., Marsh, S., Shilkrut, M., Binah, O., Guetta, J., Lejbkowicz, F., Enav, B., Shehadeh, N., Kanter, Y., Lache, O., Cohen, O., Levy, N.S. & Levy, A.P. (2003) Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circulation Research, 92, 11931200.
  • Asleh, R., Guetta, J., Kalet-Litman, S., Miller-Lotan, R. & Levy, A.P. (2005) Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circulation Research, 96, 435441.
  • Ataga, K.I., Sood, N., De, G.G., Kelly, E., Henderson, A.G., Jones, S., Strayhorn, D., Lail, A., Lieff, S. & Orringer, E.P. (2004) Pulmonary hypertension in sickle cell disease. The American Journal of Medicine, 117, 665669.
  • Ataga, K.I., Moore, C.G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A. & Orringer, E.P. (2006) Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. British Journal of Haematology, 134, 109115.
  • Bensinger, T.A. & Gillette, P.N. (1974) Hemolysis in sickle cell disease. Archives of Internal Medicine, 133, 624631.
  • Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M. & Delacourt, C. (2008) G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood, 112, 43144317.
  • Bode-Boger, S.M., Scalera, F. & Ignarro, L.J. (2007) The l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacology and Therapeutics, 114, 295306.
  • Bordi, B., Rosaria, D.A.M., Guariglia, R., Capobianco, G., Bordi, E. & Tirelli, A. (2002) A case of congenital dyserythropoietic anemia type II, Gilbert’s syndrome and malleolar trophic ulcers. Hematology, 7, 197199.
  • Boretti, F.S., Buehler, P.W., D’Agnillo, F., Kluge, K., Glaus, T., Butt, O.I., Jia, Y., Goede, J., Pereira, C.P., Maggiorini, M., Schoedon, G., Alayash, A.I. & Schaer, D.J. (2009) Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. Journal of Clinical Investigation, 119, 22712280.
  • Brittain, J.E. & Parise, L.V. (2008) The alpha4beta1 integrin in sickle cell disease. Transfusion Clinique et Biologique, 15, 1922.
  • Butthep, P., Rummavas, S., Wisedpanichkij, R., Jindadamrongwech, S., Fucharoen, S. & Bunyaratvej, A. (2002) Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia. American Journal of Hematology, 70, 100106.
  • Cappellini, M.D. (2007) Coagulation in the pathophysiology of hemolytic anemias. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 2007, 7478.
  • Cartron, J.P. & Elion, J. (2008) Erythroid adhesion molecules in sickle cell disease: effect of hydroxyurea. Transfusion Clinique et Biologique, 15, 3950.
  • Cartwright, G.E. (1966) The anemia of chronic disorders. Seminars in Hematology, 3, 351375.
  • Castro, O., Hoque, M. & Brown, B.D. (2003) Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood, 101, 12571261.
  • Champion, H.C., Bivalacqua, T.J., Takimoto, E., Kass, D.A. & Burnett, A.L. (2005) Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proceedings of the National Academy of Sciences of the United States of America, 102, 16611666.
  • Chironi, G.N., Boulanger, C.M., Simon, A., Dignat-George, F., Freyssinet, J.M. & Tedgui, A. (2009) Endothelial microparticles in diseases. Cell and Tissue Research, 335, 143151.
  • Chou, R. & DeLoughery, T.G. (2001) Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. American Journal of Hematology, 67, 197199.
  • Crary, S.E. & Buchanan, G.R. (2009) Vascular complications after splenectomy for hematologic disorders. Blood, 114, 28612868.
  • De Castro, L.M., Jonassaint, J.C., Graham, F.L., Ashley-Koch, A. & Telen, M.J. (2008) Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. American Journal of Hematology, 83, 1925.
  • De Ceulaer, K., Higgs, D.R., Weatherall, D.J., Hayes, R.J., Serjeant, B.E. & Serjeant, G.R. (1983) alpha-Thalassemia reduces the hemolytic rate in homozygous sickle-cell disease. The New England Journal of Medicine, 309, 189190.
  • Du, Z.D., Roguin, N., Milgram, E., Saab, K. & Koren, A. (1997) Pulmonary hypertension in patients with thalassemia major. American Heart Journal, 134, 532537.
  • Duits, A.J., Pieters, R.C., Saleh, A.W., Van Rosmalen, E., Katerberg, H., Berend, K. & Rojer, R.A. (1996) Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clinical Immunology and Immunopathology, 81, 9698.
  • Edney, M.T., Schned, A.R., Cendron, M., Chaffee, S. & Ellsworth, P.I. (2002) Priapism in a 15-year-old boy with congenital dyserythropoietic anemia type II (hereditary erythroblastic multinuclearity with positive acidified serum lysis test). Journal of Urology, 167, 309310.
  • Eldor, A. & Rachmilewitz, E.A. (2002) The hypercoagulable state in thalassemia. Blood, 99, 3643.
  • Embury, S.H., Dozy, A.M., Miller, J., Davis, Jr, J.R., Kleman, K.M., Preisler, H., Vichinsky, E., Lande, W.N., Lubin, B.H., Kan, Y.W. & Mentzer, W.C. (1982) Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. The New England Journal of Medicine, 306, 270274.
  • Frenette, P.S. (2004) Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion. Microcirculation, 11, 167177.
  • Gladwin, M.T. & Vichinsky, E. (2008) Pulmonary complications of sickle cell disease. New England Journal of Medicine, 359, 22542265.
  • Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. New England Journal of Medicine, 350, 886895.
  • Gramaglia, I., Sobolewski, P., Meays, D., Contreras, R., Nolan, J.P., Frangos, J.A., Intaglietta, M. & Van Der Heyde, H.C. (2006) Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nature Medicine, 12, 14171422.
  • Grisaru, D., Rachmilewitz, E.A., Mosseri, M., Gotsman, M., Lafair, J.S., Okon, E., Goldfarb, A. & Hasin, Y. (1990) Cardiopulmonary assessment in beta-thalassemia major. Chest, 98, 11381142.
  • Gyan, E., Darre, S., Jude, B., Cambier, N., Demory, J.L., Bauters, F. & Rose, C. (2001) Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy. The Hematology Journal, 2, 210211.
  • Hagar, R.W., Michlitsch, J.G., Gardner, J., Vichinsky, E.P. & Morris, C.R. (2008) Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. British Journal of Haematology, 140, 104112.
  • Haque, A.K., Gokhale, S., Rampy, B.A., Adegboyega, P., Duarte, A. & Saldana, M.J. (2002) Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Human Pathology, 33, 10371043.
  • Hayag-Barin, J.E., Smith, R.E. & Tucker, Jr, F.C. (1998) Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: a case report and review of the literature. American Journal of Hematology, 57, 8284.
  • Haynes, Jr, J., Obiako, B., King, J.A., Hester, R.B. & Ofori-Acquah, S. (2006) Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. American Journal of Physiology. Heart and Circulatory Physiology, 291, H1679H1685.
  • Hebbel, R.P., Osarogiagbon, R. & Kaul, D. (2004) The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy. Microcirculation, 11, 129151.
  • Heller, P.G., Grinberg, A.R., Lencioni, M., Molina, M.M. & Roncoroni, A.J. (1992) Pulmonary hypertension in paroxysmal nocturnal hemoglobinuria. Chest, 102, 642643.
  • Herrick, J.B. (1910) Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Archives of Internal Medicine, 6, 517521.
  • Higgs, D.R., Aldridge, B.E., Lamb, J., Clegg, J.B., Weatherall, D.J., Hayes, R.J., Grandison, Y., Lowrie, Y., Mason, K.P., Serjeant, B.E. & Serjeant, G.R. (1982) The interaction of alpha-thalassemia and homozygous sickle-cell disease. The New England Journal of Medicine, 306, 14411446.
  • Hill, A., Rother, R.P., Wang, X., Morris, S.M. Jr., Quinn-Senger, K., Kelly, R., Richards, S.J., Bessler, M., Bell, L., Hillmen, P. & Gladwin, M.T. Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. British Journal of Haematology, in press.
  • Hobbs, M.R., Udhayakumar, V., Levesque, M.C., Booth, J., Roberts, J.M., Tkachuk, A.N., Pole, A., Coon, H., Kariuki, S., Nahlen, B.L., Mwaikambo, E.D., Lal, A.L., Granger, D.L., Anstey, N.M. & Weinberg, J.B. (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet, 360, 14681475.
  • Honig, G.R., Telfer, M.C., Rosenblum, B.B. & Vida, L.N. (1989) Hb Warsaw (beta 42 Phe----Val): an unstable hemoglobin with decreased oxygen affinity. I. Hematologic and clinical expression. American Journal of Hematology, 32, 3641.
  • Hsu, L.L., Miller, S.T., Wright, E., Kutlar, A., McKie, V., Wang, W., Pegelow, C.H., Driscoll, C., Hurlet, A., Woods, G., Elsas, L., Embury, S. & Adams, R.J. (2003) Alpha Thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. Journal of Pediatric Hematology/Oncology, 25, 622628.
  • Hsu, L.L., Champion, H.C., Campbell-Lee, S.A., Bivalacqua, T.J., Manci, E.A., Diwan, B.A., Schimel, D.M., Cochard, A.E., Wang, X., Schechter, A.N., Noguchi, C.T. & Gladwin, M.T. (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood, 109, 30883098.
  • Jackson, N., Franklin, I.M. & Hughes, M.A. (1986) Recurrent priapism following splenectomy for thalassaemia intermedia. The British Journal of Surgery, 73, 678.
  • Jin, R.C., Voetsch, B. & Loscalzo, J. (2005) Endogenous mechanisms of inhibition of platelet function. Microcirculation, 12, 247258.
  • Kato, G.J. (2009) Haptoglobin halts hemoglobin’s havoc. Journal of Clinical Investigation, 119, 21402142.
  • Kato, G.J. & Gladwin, M.T. (2008) Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. Journal of the American Medical Association, 300, 26382646.
  • Kato, G.J., Martyr, S., Blackwelder, W.C., Nichols, J.S., Coles, W.A., Hunter, L.A., Brennan, M.L., Hazen, S.L. & Gladwin, M.T. (2005) Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality. British Journal of Haematology, 130, 943953.
  • Kato, G.J., Hsieh, M., Machado, R., Taylor, 6th, J., Little, J., Butman, J.A., Lehky, T., Tisdale, J. & Gladwin, M.T. (2006) Cerebrovascular disease associated with sickle cell pulmonary hypertension. American Journal of Hematology, 81, 503510.
  • Kato, G.J., Wang, Z., Machado, R.F., Blackwelder, W.C., Taylor, 6th, J.G. & Hazen, S.L. (2009) Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. British Journal of Haematology, 145, 506513.
  • Kaul, D.K., Liu, X.D., Choong, S., Belcher, J.D., Vercellotti, G.M. & Hebbel, R.P. (2004) Anti-inflammatory therapy ameliorates leukocyte adhesion and microvascular flow abnormalities in transgenic sickle mice. American Journal of Physiology. Heart and Circulatory Physiology, 287, H293H301.
  • Kaul, D.K., Liu, X.D., Zhang, X., Ma, L., Hsia, C.J. & Nagel, R.L. (2006) Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants. American Journal of Physiology. Heart and Circulatory Physiology, 291, H167H175.
  • Kim, B.J., Park, K.W., Koh, S.B., Kim, H.K., Jung, H.L., Park, M.K. & Lee, D.H. (2005) Stroke induced by splenectomy in hemoglobin Madrid: autopsy clues to the underlying mechanism. Blood Coagulation and Fibrinolysis, 16, 141144.
  • Koshy, M., Entsuah, R., Koranda, A., Kraus, A.P., Johnson, R., Bellvue, R., Flournoy-Gill, Z. & Levy, P. (1989) Leg ulcers in patients with sickle cell disease. Blood, 74, 14031408.
  • Krishnan, K., Martinez, F., Wille, R.T., Jones, R.T., Shih, D.T., Head, C., Fairbanks, V.F. & Dabich, L. (1994) Hb Washtenaw [beta 11(A8)Val-->Phe]: an electrophorectically silent, unstable, low oxygen affinity variant associated with anemia and chronic cyanosis. Hemoglobin, 18, 285295.
  • Landburg, P.P., Teerlink, T., Muskiet, F.A., Duits, A.J. & Schnog, J.J. (2008) Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis. American Journal of Hematology, 83, 577579.
  • Lee, F.S. (2008) Genetic causes of erythrocytosis and the oxygen-sensing pathway. Blood Reviews, 22, 321332.
  • Lee, M.T., Rosenzweig, E.B. & Cairo, M.S. (2007) Pulmonary hypertension in sickle cell disease. Clinical Advances in Hematology & Oncology, 5, 645653.
  • Levy, A.P., Hochberg, I., Jablonski, K., Resnick, H.E., Lee, E.T., Best, L. & Howard, B.V. (2002) Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: the Strong Heart Study. Journal of the American College of Cardiology, 40, 19841990.
  • Liem, R.I., Nevin, M.A., Prestridge, A., Young, L.T. & Thompson, A.A. (2009) Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease. Pediatric Pulmonology, 44, 281289.
  • Lode, H.N., Krings, G., Schulze-Neick, I., Dahmlow, S., Schroeder, U., Bonnet, R., Dapalma, J., Luck, W., Strau, G., Berger, F. & Gaedicke, G. (2007) Pulmonary Hypertension in a Case of Hb-Mainz Hemolytic Anemia. Journal of Pediatric Hematology/Oncology, 29, 173177.
  • Lopansri, B.K., Anstey, N.M., Weinberg, J.B., Stoddard, G.J., Hobbs, M.R., Levesque, M.C., Mwaikambo, E.D. & Granger, D.L. (2003) Low plasma arginine concentrations in children with cerebral malaria and decreased nitric oxide production. Lancet, 361, 676678.
  • Minniti, C.P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N., Onyekwere, O., Nouraie, M., Kato, G.J., Gladwin, M.T., Castro, O.L. & Gordeuk, V.R. (2009) Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica, 94, 340347.
  • Montalban, J., Lozano, P., Lu, L. & Gonzalez, A. (1986) [Paroxysmal nocturnal hemoglobinuria and priapism]. Medicina Clínica, 87, 394.
  • Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr, S.M. & Gladwin, M.T. (2005a) Dysregulated Arginine Metabolism, Hemolysis-Associated Pulmonary Hypertension and Mortality in Sickle Cell Disease. Journal of the American Medical Association, 294, 8190.
  • Morris, C.R., Kuypers, F.A., Kato, G.J., Lavrisha, L., Larkin, S., Singer, T. & Vichinsky, E.P. (2005b) Hemolysis-associated pulmonary hypertension in thalassemia. Annals of the New York Academy of Sciences, 1054, 481485.
  • Morris, C.R., Suh, J.H., Hagar, W., Larkin, S., Bland, D.A., Steinberg, M.H., Vichinsky, E.P., Shigenaga, M., Ames, B., Kuypers, F.A. & Klings, E.S. (2008) Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood, 111, 402410.
  • Muller-Soyano, A., Tovar de Roura, E., Duke, P.R., De Acquatella, G.C., Arends, T., Guinto, E. & Beutler, E. (1976) Pyruvate kinase deficiency and leg ulcers. Blood, 47, 807813.
  • Nelson, S.C., Adade, B.B., McDonough, E.A., Moquist, K.L. & Hennessy, J.M. (2007) High prevalence of pulmonary hypertension in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 29, 334337.
  • Neonato, M.G., Guilloud-Bataille, M., Beauvais, P., Begue, P., Belloy, M., Benkerrou, M., Ducrocq, R., Maier-Redelsperger, M., De Montalembert, M., Quinet, B., Elion, J., Feingold, J. & Girot, R. (2000) Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. European Journal of Haematology, 65, 155164.
  • Nolan, V.G., Wyszynski, D.F., Farrer, L.A. & Steinberg, M.H. (2005a) Hemolysis-associated priapism in sickle cell disease. Blood, 106, 32643267.
  • Nolan, V.G., Baldwin, C., Ma, Q., Wyszynski, D.F., Amirault, Y., Farrell, J.J., Bisbee, A., Embury, S.H., Farrer, L.A. & Steinberg, M.H. (2005b) Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. British Journal of Haematology, 128, 266272.
  • Nolan, V.G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D.F., Farrell, J.J., Sebastiani, P., Farrer, L.A. & Steinberg, M.H. (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. British Journal of Haematology, 133, 570578.
  • Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood, 91, 288294.
  • Onyekwere, O.C., Campbell, A., Teshome, M., Onyeagoro, S., Sylvan, C., Akintilo, A., Hutchinson, S., Ensing, G., Gaskin, P., Kato, G., Rana, S., Kwagyan, J., Gordeuk, V., Williams, J. & Castro, O. (2008) Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatric Cardiology, 29, 309312.
  • Pashankar, F.D., Carbonella, J., Bazzy-Asaad, A. & Friedman, A. (2008) Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics, 121, 777782.
  • Pavlovic, S., Kuzmanovic, M., Urosevic, J., Poznanic, J., Zoranovic, T., Djordjevic, V., Rasovic, N., Bunjevacki, G., Cvorkov-Drazic, M. & Colovic, M. (2004) Severe central nervous system thrombotic events in hemoglobin Sabine patient. European Journal of Haematology, 72, 6770.
  • Pluta, R.M., Dejam, A., Grimes, G., Gladwin, M.T. & Oldfield, E.H. (2005) Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. Journal of the American Medical Association, 293, 14771484.
  • Pluta, R.M., Hansen-Schwartz, J., Dreier, J., Vajkoczy, P., Macdonald, R.L., Nishizawa, S., Kasuya, H., Wellman, G., Keller, E., Zauner, A., Dorsch, N., Clark, J., Ono, S., Kiris, T., Leroux, P. & Zhang, J.H. (2009) Cerebral vasospasm following subarachnoid hemorrhage: time for a new world of thought. Neurological Research, 31, 151158.
  • Reiter, C.D., Wang, X., Tanus-Santos, J.E., Hogg, N., Cannon, III, R.O., Schechter, A.N. & Gladwin, M.T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nature Medicine, 8, 13831389.
  • Rother, R.P., Bell, L., Hillmen, P. & Gladwin, M.T. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. Journal of the American Medical Association, 293, 16531662.
  • Rothman, S.M., Fulling, K.H. & Nelson, J.S. (1986) Sickle cell anemia and central nervous system infarction: a neuropathological study. Annals of Neurology, 20, 684690.
  • Ruf, A., Pick, M., Deutsch, V., Patscheke, H., Goldfarb, A., Rachmilewitz, E.A., Guillin, M.C. & Eldor, A. (1997) In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with beta-thalassaemia major. British Journal of Haematology, 98, 5156.
  • Sadler, J.E. (2008) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood, 112, 1118.
  • Scalera, F., Kielstein, J.T., Martens-Lobenhoffer, J., Postel, S.C., Tager, M. & Bode-Boger, S.M. (2005) Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase. Journal of the American Society of Nephrology, 16, 892898.
  • Schaer, D.J., Alayash, A.I. & Buehler, P.W. (2007) Gating the radical hemoglobin to macrophages: the anti-inflammatory role of CD163, a scavenger receptor. Antioxidants Redox Signaling, 9, 991999.
  • Schafer, A., Wiesmann, F., Neubauer, S., Eigenthaler, M., Bauersachs, J. & Channon, K.M. (2004) Rapid regulation of platelet activation in vivo by nitric oxide. Circulation, 109, 18191822.
  • Schilling, R.F., Gangnon, R.E. & Traver, M.I. (2008) Delayed adverse vascular events after splenectomy in hereditary spherocytosis. Journal of Thrombosis and Haemostasis, 6, 12891295.
  • Schnog, J.B., Rojer, R.A., Mac Gillavry, M.R., Ten Cate, H., Brandjes, D.P. & Duits, A.J. (2003) Steady-state sVCAM-1 serum levels in adults with sickle cell disease. Annals of Hematology, 82, 109113.
  • Schnog, J.B., Teerlink, T., Van Der Dijs, F.P., Duits, A.J. & Muskiet, F.A. (2005) Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. Annals of Hematology, 84, 282286.
  • Schnog, J.J., Hovinga, J.A., Krieg, S., Akin, S., Lammle, B., Brandjes, D.P., Mac Gillavry, M.R., Muskiet, F.D. & Duits, A.J. (2006) ADAMTS13 activity in sickle cell disease. American Journal of Hematology, 81, 492498.
  • Sedrak, A., Rao, S.P., Miller, S.T., Hekmat, V. & Rao, M. (2009) A prospective appraisal of pulmonary hypertension in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 31, 97100.
  • Setty, B.N. & Betal, S.G. (2008) Microvascular endothelial cells express a phosphatidylserine receptor: a functionally active receptor for phosphatidylserine-positive erythrocytes. Blood, 111, 905914.
  • Setty, B.N., Kulkarni, S. & Stuart, M.J. (2002) Role of erythrocyte phosphatidylserine in sickle red cell-endothelial adhesion. Blood, 99, 15641571.
  • Setty, B.N., Stuart, M.J., Dampier, C., Brodecki, D. & Allen, J.L. (2003) Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet, 362, 14501455.
  • Shet, A.S., Aras, O., Gupta, K., Hass, M.J., Rausch, D.J., Saba, N., Koopmeiners, L., Key, N.S. & Hebbel, R.P. (2003) Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood, 102, 26782683.
  • Singer, S.T. & Ataga, K.I. (2008) Hypercoagulability in sickle cell disease and beta-thalassemia. Current Molecular Medicine, 8, 639645.
  • Singer, S.T., Kuypers, F.A., Styles, L., Vichinsky, E.P., Foote, D. & Rosenfeld, H. (2006) Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. American Journal of Hematology, 81, 670675.
  • Solovey, A., Gui, L., Key, N.S. & Hebbel, R.P. (1998) Tissue factor expression by endothelial cells in sickle cell anemia. The Journal Of Clinical Investigation, 101, 18991904.
  • Steinberg, M.H., Rosenstock, W., Coleman, M.B., Adams, J.G., Platica, O., Cedeno, M., Rieder, R.F., Wilson, J.T., Milner, P. & West, S. (1984) Effects of thalassemia and microcytosis on the hematologic and vasoocclusive severity of sickle cell anemia. Blood, 63, 13531360.
  • Stevens, D.M., Shupack, J.L., Javid, J. & Silber, R. (1977) Ulcers of the leg in thalassemia. Archives of Dermatology, 113, 15581560.
  • Strijbos, M.H., Landburg, P.P., Nur, E., Teerlink, T., Leebeek, F.W., Rijneveld, A.W., Biemond, B.J., Sleijfer, S., Gratama, J.W., Duits, A.J. & Schnog, J.J. (2009) Circulating endothelial cells: a potential parameter of organ damage in sickle cell anemia? Blood Cells, Molecules, and Diseases, 43, 6367.
  • Taher, A., Abou-Mourad, Y., Abchee, A., Zalouaa, P. & Shamseddine, A. (2002) Pulmonary thromboembolism in beta-thalassemia intermedia: are we aware of this complication? Hemoglobin, 26, 107112.
  • Taher, A.T., Otrock, Z.K., Uthman, I. & Cappellini, M.D. (2008) Thalassemia and hypercoagulability. Blood Reviews, 22, 283292.
  • Thuret, I., Bardakdjian, J., Badens, C., Wajcman, H., Galacteros, F., Vanuxem, D., Perrimond, H., Giraud, F. & Lena-Russo, D. (1996) Priapism following splenectomy in an unstable hemoglobin: hemoglobin Olmsted beta 141 (H19) Leu-->Arg. American Journal of Hematology, 51, 133136.
  • Vanscheidt, W., Leder, O., Vanscheidt, E., Wokalek, H., Wilmer, J., Hofmann, E. & Schopf, E. (1990) Leg ulcers in a patient with spherocytosis: a clinicopathological report. Dermatologica, 181, 5659.
  • Verhamme, P. & Hoylaerts, M.F. (2006) The pivotal role of the endothelium in haemostasis and thrombosis. Acta Clinica Belgica, 61, 213219.
  • Villagra, J., Shiva, S., Hunter, L.A., Machado, R.F., Gladwin, M.T. & Kato, G.J. (2007) Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension and nitric oxide scavenging by cell-free hemoglobin. Blood, 110, 21662172.
  • Voskaridou, E., Tsetsos, G., Tsoutsias, A., Spyropoulou, E., Christoulas, D. & Terpos, E. (2007) Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica, 92, 738743.
  • Westerman, M., Pizzey, A., Hirschman, J., Cerino, M., Weil-Weiner, Y., Ramotar, P., Eze, A., Lawrie, A., Purdy, G., Mackie, I. & Porter, J. (2008) Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy. British Journal of Haematology, 142, 126135.
  • Westwick, J., Watson-Williams, E.J., Krishnamurthi, S., Marks, G., Ellis, V., Scully, M.F., White, J.M. & Kakkar, V.V. (1983) Platelet activation during steady state sickle cell disease. Journal of Medicine, 14, 1736.
  • Wood, K.C., Hebbel, R.P. & Granger, D.N. (2005) Endothelial cell NADPH oxidase mediates the cerebral microvascular dysfunction in sickle cell transgenic mice. FASEB Journal, 19, 989991.
  • Wun, T., Paglieroni, T., Rangaswami, A., Franklin, P.H., Welborn, J., Cheung, A. & Tablin, F. (1998) Platelet activation in patients with sickle cell disease. British Journal of Haematology, 100, 741749.
  • Yater, W.M. & Hansmann, G.H. (1936) Sickle-cell anemia: a new cause of cor pulmonale: report of two cases with Numerous disseminated occlusions of the small pulmonary arteries. American Journal of the Medical Sciences, 191, 474484.
  • Yeo, T.W., Lampah, D.A., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y.R., Darcy, C.J., Granger, D.L., Weinberg, J.B., Lopansri, B.K., Price, R.N., Duffull, S.B., Celermajer, D.S. & Anstey, N.M. (2007) Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. Journal of Experimental Medicine, 204, 26932704.
  • Yuditskaya, S., Tumblin, A., Hoehn, G.T., Wang, G., Drake, S.K., Xu, X., Ying, S., Chi, A.H., Remaley, A.T., Shen, R.F., Munson, P.J., Suffredini, A.F. & Kato, G.J. (2009) Proteomic identification of altered apolipoprotein patterns in pulmonary hypertension and vasculopathy of sickle cell disease. Blood, 113, 11221128.
  • Yuhanna, I.S., Zhu, Y., Cox, B.E., Hahner, L.D., Osborne-Lawrence, S., Lu, P., Marcel, Y.L., Anderson, R.G., Mendelsohn, M.E., Hobbs, H.H. & Shaul, P.W. (2001) High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase. Nature Medicine, 7, 853857.
  • Zennadi, R., De Castro, L., Eyler, C., Xu, K., Ko, M. & Telen, M.J. (2008) Role and regulation of sickle red cell interactions with other cells: ICAM-4 and other adhesion receptors. Transfusion Clinique et Biologique, 15, 2328.
  • Zhang, Y., Qui, Y., Zhu, J. & Gao, D. (2007) Pulmonary hypertension associated with autoimmune hemolytic anemia: a case report. International Journal of Cardiology, 115, e1e2.
  • Zhou, Z., Han, H., Cruz, M.A., Lopez, J.A., Dong, J.F. & Guchhait, P. (2009) Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thrombosis and Haemostasis, 101, 10701077.